Quantcast ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data - Congoo
 
 
Log In
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data
Have an interest in this Story?
Sign Up for Real-Time email updates
SmartBrief  | November 07, 2009

NEW YORK-- (BUSINESS WIRE) -- (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue ...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Mark Palmer Mark Palmer
Founder
Internet consultancies
Martin P. Lee Martin P. Lee
Associate Lecturer
Knowledge Management

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2010 Congoo.com. All Rights Reserved.